FDA Releases Two Draft Guidances On Social Media for Drug, Device Industry

The Food and Drug Administration released two draft guidance documents for the drug and device industries on presenting risk/benefit information and correcting third-party misinformation on social media.

However, attorneys told Bloomberg BNA that the documents issued June 17 may not provide that much new information for FDA-regulated companies and have limited usefulness.

The agency asked that comments on both draft guidance documents be submitted by Sept. 16. The docket number for the guidance on presenting risk/benefit information is FDA-2014-D-0397 and the docket number for the guidance on correcting third-party misinformation is FDA-2014-D-0447. Notices announcing the draft guidances are to be ...